Nephrology clinical (TRPM7)

26487689 PDF 2015. Magnesium Modifies the Impact of Calcitriol Treatment on Vascular Calcification in Experimental Chronic Kidney Disease.Template:26487689
32047249 PDF 2020. TRPM7 contributes to progressive nephropathy.Template:32047249
38093238 PDF 2023. Serum magnesium level and cardiac valve calcification in hemodialysis patients.Template:38093238
37582785 PDF 2023. The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients.Template:37582785
35656113 PDF 2022. Vascular Calcification in Chronic Kidney Disease: An Update and Perspective.Template:35656113
33917965 PDF 2021. Vascular Calcification in Chronic Kidney Disease: Diversity in the Vessel Wall.Template:33917965
33632150 PDF 2021. Low plasma magnesium concentration and future abdominal aortic calcifications in moderate chronic kidney disease.Template:33632150
29478069 PDF 2018. Magnesium in Chronic Kidney Disease: Should We Care?Template:29478069

28645983 PDF 2017. The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.'

28385153 PDF 2017. Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional study.Template:28385153
27771720 PDF 2016. Dietary Magnesium and Kidney Function Decline: The Healthy Aging in Neighborhoods of Diversity across the Life Span Study.Template:27771720
27419135 PDF 2016. Magnesium Attenuates Phosphate-Induced Deregulation of a MicroRNA Signature and Prevents Modulation of Smad1 and Osterix during the Course of Vascular Calcification.Template:27419135
23506202 PDF 2014. Phosphate: an old bone molecule but new cardiovascular risk factor.Template:23506202
38222032 PDF 2024. Similarities and Differences of Vascular Calcification in Diabetes and Chronic Kidney Disease.Template:38222032
37915933 PDF 2023. Hypomagnesemia: a potential underlooked cause of persistent vitamin D deficiency in chronic kidney disease.Template:37915933
36388921 PDF 2022. The role of extracellular vesicles in vascular calcification in chronic kidney disease.Template:36388921
35453928 PDF 2022. Magnesium-A More Important Role in CKD-MBD than We Thought.Template:35453928
34901204 PDF 2021. IL-18 Mediates Vascular Calcification Induced by High-Fat Diet in Rats With Chronic Renal Failure.Template:34901204

34689162 PDF 2021. Deletion of soluble epoxide hydrolase suppressed chronic kidney disease-related vascular calcification by restoring Sirtuin 3 expression.'

34504876 PDF 2021. beta-Hydroxybutyric Inhibits Vascular Calcification via Autophagy Enhancement in Models Induced by High Phosphate.Template:34504876

33282857 PDF 2020. The Role of Disturbed Mg Homeostasis in Chronic Kidney Disease Comorbidities.'

30887097 PDF 2019. Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia.Template:30887097
25852855 PDF 2014. Magnesium: a renewed player of vascular ageing in diabetic CKD patients?Template:25852855
26069821 PDF 2012. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival.Template:26069821

35232774 PDF 2022. Interventions To Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials.'

34793336 PDF 2022. SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via Runx2 in chronic kidney disease.Template:34793336
34003800 PDF 2021. ALKBH1-demethylated DNA N6-methyladenine modification triggers vascular calcification via osteogenic reprogramming in chronic kidney disease.Template:34003800
33369187 PDF 2021. Role of gut microbiota-derived metabolites on vascular calcification in CKD.Template:33369187
35330975 PDF 2021. Kv1.3 Channel Inhibition Limits Uremia-Induced Calcification in Mouse and Human Vascular Smooth Muscle.Template:35330975
31036759 PDF 2019. A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD.Template:31036759
30977017 PDF 2019. Hypomagnesemia is not an independent risk factor for mortality in Japanese maintenance hemodialysis patients.Template:30977017
30826804 PDF 2019. Low serum magnesium is associated with faster decline in kidney function: the Dallas Heart Study experience.Template:30826804
29495444 PDF 2018. Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials.Template:29495444
26885127 PDF 2015. Proton pump inhibitors use in hemodialysis patients and serum magnesium levels.Template:26885127
26089881 PDF 2015. Low Magnesium Levels and FGF-23 Dysregulation Predict Mitral Valve Calcification as well as Intima Media Thickness in Predialysis Diabetic Patients.Template:26089881
35134986 PDF 2022. Dietary magnesium supplementation inhibits abdominal vascular calcification in an experimental animal model of chronic kidney disease.Template:35134986

33851114 PDF 2021. Serum Magnesium and Cardiovascular Outcomes and Mortality in CKD: The Chronic Renal Insufficiency Cohort (CRIC).'

33851109 PDF 2021. Magnesium and Cardiovascular Disease in CKD: The Mysteries of a Humble Divalent Cation.Template:33851109
33481059 PDF 2021. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.Template:33481059
33374019 PDF 2022. Magnesium to prevent kidney disease-associated vascular calcification: crystal clear?Template:33374019
32494818 PDF 2020. Low serum magnesium as a risk factor for peripheral artery disease in chronic kidney disease: an open verdict.Template:32494818
31194171 PDF 2019. Diabetes Mellitus Modifies the Associations of Serum Magnesium Concentration With Arterial Calcification and Stiffness in Incident Hemodialysis Patients.Template:31194171
29704284 PDF 2018. Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease.Template:29704284
29142966 PDF 2017. Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial.Template:29142966
25272232 PDF 2015. Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease.Template:25272232
25227765 PDF 2015. Magnesium in CKD: more than a calcification inhibitor?Template:25227765

23486515 PDF 2013. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.'

34143857 PDF 2021. Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5.Template:34143857
33003628 PDF 2020. Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.Template:33003628
30813254 PDF 2019. Magnesium: A Magic Bullet for Cardiovascular Disease in Chronic Kidney Disease?Template:30813254
28178182 PDF 2017. Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.Template:28178182
27023783 PDF 2016. Hypomagnesemia Is Associated with Increased Mortality among Peritoneal Dialysis Patients.Template:27023783

25545498 PDF 2014. Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study.'

38092856 PDF 2023. Lower product of magnesium x potassium is associated with higher mortality in chronic hemodialysis patients: a cohort study.'

36699036 PDF 2022. Fibroblast growth factor 23 is independently associated with renal magnesium handling in patients with chronic kidney disease.'

34584906 PDF 2021. Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease.Template:34584906
34322504 PDF 2021. The Association Between Exposure to Low Magnesium Blood Levels After Renal Transplantation and Cardiovascular Morbidity and Mortality.Template:34322504
33614731 PDF 2021. Prognostic Value of Serum Magnesium in Mortality Risk among Patients on Hemodialysis: A Meta-Analysis of Observational Studies.Template:33614731
33159963 PDF 2021. Targeting fibroblast growth factor 23-responsive pathways uncovers controlling genes in kidney mineral metabolism.Template:33159963
32494148 PDF 2020. Vascular Calcification: An Important Understanding in Nephrology.Template:32494148
32066594 PDF 2020. Electrolyte Disorders in Kidney Transplantation.Template:32066594
30430111 PDF 2018. Nutrition Trends in Kidney Transplant Recipients: the Importance of Dietary Monitoring and Need for Evidence-Based Recommendations.Template:30430111
30333977 PDF 2018. Electrolyte and Acid-Base Disorders in the Renal Transplant Recipient.Template:30333977
29969455 PDF 2018. Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.Template:29969455
29799851 PDF 2018. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.Template:29799851
29725641 PDF 2018. Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients.Template:29725641
24944752 PDF 2014. Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?Template:24944752
24255887 PDF 2013. Lowering vascular calcification burden in chronic kidney disease: Is it possible?Template:24255887
24175241 PDF 2012. Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication.Template:24175241
26069820 PDF 2012. Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients.Template:26069820